Problem statement: Answer the multiple choice question.
Query: Which drug exhibits a 5.189% human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a O=C(CN1C(=O)NC2(CCCCC2)C1=O)Nc1cc(C(F)(F)F)ccc1N1CCCCC1
b CCC(C)[C@H](NC(=O)NC1CCCc2ccccc21)C(=O)OC
c COc1ccccc1CC(=O)N1CCN(c2ccccc2F)CC1
Answer: b. CCC(C)[C@H](NC(=O)NC1CCCc2ccccc21)C(=O)OC
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(C)[C@H](NC(=O)NC1CCCc2ccccc21)C(=O)OC
CCC(C)[C@H](NC(=O)NC1CCCc2ccccc21)C(=O)OC
methyl (2S)-3-methyl-2-(1,2,3,4-tetrahydronaphthalen-1-ylcarbamoylamino)pentanoate